Tianjin Era Biology Technology Co., Ltd.

Business Type:Manufacturer

Main Products: In Vitro Diagnostic COVID testInvasive fungal disease diagnosticAspergillosis testCryptococcosis testDiagnostic instrumentHealthcare protectorAntigen rapid testClinical diagnosticInfectious disease test

view on mobile

COVID-I9 Antigen Lateral Flow Assay

Medical & Health & Beauty Epidemic prevention materials

FOB Price:US$ 1.50 / Piece(s)

MOQ:10000 Piece(s)

Payment Method :

Keywords:COVID rapid test antigen SARS-Cov-2 

Add to Favorites

Product Category: Medical & Health & Beauty > Epidemic prevention materials Trademark:
Product Package: Specifications:
Place of Origin: Port: Tianjin

COV1D-19 Antigen Lateral Flow Assay


[Intended Use]
The COV1D-19 Antigen Lateral Flow Assay is a lateral flow immunoassay intend for the qualitative detection SARS-CoV--2 nucleocapsid antigens in nasopharyngeal swab and oropharyngeal swab from individuals who are suspected of COV1D-19 by their healthcare provider.
[Component]

  • COV1D-19 Antigen Detection Cassette: 20

  • Sample Extraction Reagent: 10.0 mL/vial×1 vial

  • Sterilized Swab: 20

  • Extraction Tube: 20

  • Dropper Tip: 20

  • Package Insert

[Storage Conditions and Validity]
Store at 2-30℃ for 12 months, store in a dry and cool place.
The COV1D-19 Antigen Detection Cassette should be used within 1h when taken out from aluminum foil bag.
The Sample Extraction Reagent can be stored for 1 month after opening.
[Warnings and Precautions]

  • For in vitro diagnostic use only.

  • For healthcare professionals and professionals at point of care sites.

  • Do not use this product as the sole basis to diagnose or exclude SARS-CoV--2 infection or to inform infection status of COV1D-19.

  • Do not use after the expiration date.

  • Please read all the information in this leaflet before performing the test.

  • The test cassette should remain in the sealed pouch until use.

  • All specimens should be considered potentially hazardous and handled in the same manner as an infectious agent.

  • The used test cassette should be discarded according to federal, state and local regulations.

[Specimen]

  • Nasopharyngeal Swab Sample

  • Oropharyngeal Swab Sample

[Test Procedure]

  1. Allow the test device and specimens to equilibrate to temperature (15-30℃ or 59- 86℉) prior to testing.

  2. Remove the test cassette from the aluminum foil bag.

  3. Reverse the specimen extraction tube, holding the specimen extraction tube up right, transfer 2 drops (approximately 60 μL) to the specimen well(S) of the test cassette, then start the timer. See illustration below.

  4. Wait for colored lines to appear. Interpret the test results at 15 minutes. Do not red results after 20 minutes.

[Interpretation of results]
Positive: Two lines appear. One colored line should be in the control region (C), and another apparent colored line adjacent should be in the test line (T).
Negative: One colored line appears in the control region (C). No line appears in the test line (T).
Invalid: Control line fails to appear.


Contact Name: Miss Fiona Fu Contact Email: fi****a@era-bio.com
Contact Job Title: Supplier Contact Mob: 182***022
Contact Tel: Contact Fax:
Address: Genobio Bldg., Anzheng Road, Tourism Area, Tianjin, 300480, P.R. China Website: http://www.era-bio.com/

Our mission is to provide comprehensive invasive fungal disease diagnostic solutions Era Biology Group, started business operation in 1997, is one of the leaders and pioneers of invasive fungal disease diagnosis around the world. Now we have eight subsidaries: Beijing Gold Mountainriver Tech Development Co., Ltd., Genobio Pharmaceutical Co., Ltd., Era Biology (Shanghai) Co., Ltd., Era Biology (Guangzhou) Co., Ltd., Era Biology (Suzhou) Co., Ltd., Beihai Sinlon Biotech Co., Ltd., Era Biology Group, LLC., and Era Biology (Canada) Co., Ltd.. Era Biology has passed the authentications of CMD ISO 9001, ISO 13485, Korea GMP and North America MDSAP, and has most products certificated by CE, NMPA and FSC. In China, Era Biology, joint National Center for Clinical Laboratories etc, successfully drafted the industrial standard of "Fungus (1-3)-β-D-Glucan Test" in 2017. There are totally 2433 tertiary-level hospitals across the country, in which over 80% of these hospitals are users of our products. Globally, our products are exported to more than 30 countries and regions around the world. Our products are rapid, easy to use, quantitative, and accurate, which are of great value in early diagnostics for invasive fungal infection. As a professional supplier in invasive fungal disease detection, we are not only providing quality products, but also focusing on customized services, which allow us to meet your specific needs such as training, experimental technical guidance, troubleshooting and so on. Our goal is to provide better solutions through innovation

Products of the same category